請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/82365完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 董鈺琪(Yu-Chi Tung) | |
| dc.contributor.author | Chih-Hsien Chen | en |
| dc.contributor.author | 陳芷嫻 | zh_TW |
| dc.date.accessioned | 2022-11-25T07:29:46Z | - |
| dc.date.available | 2023-12-31 | |
| dc.date.copyright | 2021-07-20 | |
| dc.date.issued | 2021 | |
| dc.date.submitted | 2021-07-05 | |
| dc.identifier.citation | 1.Standards of medical care in diabetes-2014. Diabetes Care 2014;37:S14-S80. doi: 10.2337/dc14-S014. 2.Bommer C, Sagalova V, Heesemann E, et al. Global Economic Burden of Diabetes in Adults: Projections From 2015 to 2030. Diabetes Care 2018;41:963-70. doi: 10.2337/dc17-1962. 3.Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2014;103:137-49. doi: 10.1016/j.diabres.2013.11.002. 4.Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 1997;14 Suppl 5:S1-85. 5.Gu D, Reynolds K, Duan X, et al. Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetologia 2003;46:1190-8. doi: 10.1007/s00125-003-1167-8. 6.Dawson KG, Gomes D, Gerstein H, Blanchard JF, Kahler KH. The Economic Cost of Diabetes in Canada, 1998. Diabetes Care 2002;25:1303. doi: 10.2337/diacare.25.8.1303. 7.戴東原. 糖尿病在台灣的現況. 中華民國內分泌暨糖尿病學會會刊 2008;21:8-9. doi:10.7101/ED.200801.0008. 8.Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives. The Lancet 2013;382:260-72. doi: https://doi.org/10.1016/S0140-6736(13)60687-X. 9.Wen CP, Cheng TYD, Tsai MK, et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. The Lancet 2008;371:2173-82. doi: https://doi.org/10.1016/S0140-6736(08)60952-6. 10.Coresh J, Byrd-Holt D, Astor BC, et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 2005;16:180-8.doi: 10.1681/asn.2004070539. 11.Plantinga LC, Boulware LE, Coresh J, et al. Patient Awareness of Chronic Kidney Disease: Trends and Predictors. Archives of Internal Medicine 2008;168:2268-75. doi: 10.1001/archinte.168.20.2268. 12.Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureThe JNC 7 Report. JAMA 2003;289:2560-71. doi: 10.1001/jama.289.19.2560. 13.Coresh J, Selvin E, Stevens LA, et al. Prevalence of Chronic Kidney Disease in the United States. JAMA 2007;298:2038-47. doi: 10.1001/jama.298.17.2038. 14.Kanji Z, Powe CE, Wenger JB, et al. Genetic variation in APOL1 associates with younger age at hemodialysis initiation. Journal of the American Society of Nephrology : JASN 2011;22:2091-7. doi: 10.1681/ASN.2010121234. 15.Lin J-L, Lin-Tan D-T, Li Y-J, Chen K-H, Huang Y-L. Low-level Environmental Exposure to Lead and Progressive Chronic Kidney Diseases. The American Journal of Medicine 2006;119:707.e1-.e9. doi: 10.1016/j.amjmed.2006.01.005. 16.楊翼寧, 陳銳溢, 王憲奕, 鄭高珍. 糖尿病腎病變的診斷與治療. 內科學誌 2018;29:240-9. doi: 10.6314/JIMT.201808_29(4).05. 17.Huang YY, Lin KD, Jiang YD, et al. Diabetes-related kidney, eye, and foot disease in Taiwan: an analysis of the nationwide data for 2000-2009. J Formos Med Assoc 2012;111:637-44. doi: 10.1016/j.jfma.2012.09.006. 18.Chuang L-M, Tsai ST, Huang BY, Tai TY. The status of diabetes control in Asia—a cross-sectional survey of 24 317 patients with diabetes mellitus in 1998. Diabetic Medicine 2002;19:978-85. doi: https://doi.org/10.1046/j.1464-5491.2002.00833.x. 19.Yang W-C, Hwang S-J, Nephrology TSo. Incidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: the impact of national health insurance. Nephrology Dialysis Transplantation 2008;23:3977-82. doi: 10.1093/ndt/gfn406. 20.Yang W, Xie D, Anderson AH, et al. Association of kidney disease outcomes with risk factors for CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study. Am J Kidney Dis 2014;63:236-43. doi: 10.1053/j.ajkd.2013.08.028. 21.李曉伶, 吳肖琪. 台灣慢性病人醫療利用之探討－以慢性腎臟病、糖尿病及高血壓為例. 台灣公共衛生雜誌 2013;32:231-9. doi: 10.6288/TJPH2013-32-03-03. 22.Institute of Medicine Committee on Quality of Health Care in A. In: Kohn LT, Corrigan JM, Donaldson MS, eds. To Err is Human: Building a Safer Health System. Washington (DC): National Academies Press (US) Copyright 2000 by the National Academy of Sciences. All rights reserved., 2000. 23.Institute of Medicine Committee on Quality of Health Care in A. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington (DC): National Academies Press (US) Copyright 2001 by the National Academy of Sciences. All rights reserved., 2001. 24.廖慧娟. 論質計酬之健保制度. 醫療品質雜誌 2012;6:44-9. doi: 10.30160/JHQ.201209.0010. 25.Gosden T, Forland F, Kristiansen IS, et al. Capitation, salary, fee-for-service and mixed systems of payment: effects on the behaviour of primary care physicians. Cochrane database of systematic reviews (Online) 2000. 26.陳啟禎, 鄭守夏. 照護連續性之文獻回顧. 台灣公共衛生雜誌 2013;32:116-28. doi: 10.6288/TJPH2013-32-02-03. 27.Hennen BK. Continuity of care in family practice. Part 1: dimensions of continuity. Journal of Family Practice 1975;2:371-2. 28.Rogers J, Curtis P. The concept and measurement of continuity in primary care. American Journal of Public Health 1980;70:122-7. doi: 10.2105/AJPH.70.2.122. 29.Haggerty JL, Reid RJ, Freeman GK, Starfield BH, Adair CE, McKendry R. Continuity of care: A multidisciplinary review. British Medical Journal 2003;327:1219-21. doi: 10.1136/bmj.327.7425.1219. 30.Jee SH, Cabana MD. Indices for Continuity of Care: A Systematic Review of the Literature. Medical Care Research and Review 2006;63:158-88. doi: 10.1177/1077558705285294. 31.O'Connor PJ, Desai J, Rush WA, Cherney LM, Solberg LI, Bishop DB. Is having a regular provider of diabetes care related to intensity of care and glycemic control? J Fam Pract 1998;47:290-7. 32.Parchman ML, Pugh JA, Noël PH, Larme AC. Continuity of Care, Self-Management Behaviors, and Glucose Control in Patients With Type 2 Diabetes. Medical Care 2002;40. 33.Christakis DA, Mell L, Koepsell TD, Zimmerman FJ, Connell FA. Association of Lower Continuity of Care With Greater Risk of Emergency Department Use and Hospitalization in Children. Pediatrics 2001;107:524. doi: 10.1542/peds.107.3.524. 34.Gill JM, Mainous Iii AG, Nsereko M. The effect of continuity of care on emergency department use. Archives of Family Medicine 2000;9:333-8. doi: 10.1001/archfami.9.4.333. 35.Shin DW, Cho J, Yang HK, et al. Impact of Continuity of Care on Mortality and Health Care Costs: A Nationwide Cohort Study in Korea. The Annals of Family Medicine 2014;12:534. doi: 10.1370/afm.1685. 36.Hussey PS, Schneider EC, Rudin RS, Fox DS, Lai J, Pollack CE. Continuity and the Costs of Care for Chronic Disease. JAMA Internal Medicine 2014;174:742-8. doi: 10.1001/jamainternmed.2014.245. 37.Cheng S-H, Hou Y-F, Chen C-C. Does continuity of care matter in a health care system that lacks referral arrangements? Health Policy and Planning 2011;26:157-62. doi: 10.1093/heapol/czq035. 38.Cheng S-H, Chen C-C, Hou Y-F. A Longitudinal Examination of Continuity of Care and Avoidable Hospitalization: Evidence From a Universal Coverage Health Care System. Archives of Internal Medicine 2010;170:1671-7. doi: 10.1001/archinternmed.2010.340. 39.Lin W, Huang IC, Wang SL, Yang MC, Yaung CL. Continuity of diabetes care is associated with avoidable hospitalizations: evidence from Taiwan's National Health Insurance scheme. Int J Qual Health Care 2010;22:3-8. doi: 10.1093/intqhc/mzp059. 40.Chen CC, Chen SH. Better continuity of care reduces costs for diabetic patients. Am J Manag Care 2011;17:420-7. 41.Liao P-J, Lin Z-Y, Huang J-C, Hsu K-H. The Relationship Between Type 2 Diabetic Patients’ Early Medical Care–Seeking Consistency to the Same Clinician and Health Care System and Their Clinical Outcomes. Medicine 2015;94. 42.Chen C-C, Cheng S-H. Does pay-for-performance benefit patients with multiple chronic conditions? Evidence from a universal coverage health care system. Health Policy and Planning 2016;31:83-90. doi: 10.1093/heapol/czv024. 43.Chi MJ, Chou KR, Pei D, et al. Effects and Factors Related to Adherence to A Diabetes Pay-for-Performance Program: Analyses of a National Health Insurance Claims Database. Journal of the American Medical Directors Association 2016;17:613-9. doi: 10.1016/j.jamda.2016.02.033. 44.Pan CC, Kung PT, Chiu LT, Liao YP, Tsai WC. Patients with diabetes in pay-for-performance programs have better physician continuity of care and survival. Am J Manag Care 2017;23:e57-e66. 45.Lee TT, Cheng SH, Chen CC, Lai MS. A pay-for-performance program for diabetes care in Taiwan: A preliminary assessment. American Journal of Managed Care 2010;16:65-9. 46.Cheng SH, Lee TT, Chen CC. A longitudinal examination of a pay-for-performance program for diabetes care: Evidence from a natural experiment. Medical Care 2012;50:109-16. doi: 10.1097/MLR.0b013e31822d5d36. 47.Chen JY, Tian H, Taira Juarez D, et al. The effect of a PPO pay-for-performance program on patients with diabetes. Am J Manag Care 2010;16:e11-9. 48.Huang Y-C, Lee M-C, Chou Y-J, Huang N. Disease-specific Pay-for-Performance Programs: Do the P4P Effects Differ Between Diabetic Patients With and Without Multiple Chronic Conditions? Medical Care 2016;54. 49.Liao P-J, Lin T-Y, Wang T-C, et al. Long-Term and Interactive Effects of Pay-For-Performance Interventions among Diabetic Nephropathy Patients at the Early Chronic Kidney Disease Stage. Medicine 2016;95. 50.Chen Y-C, Lee CT-C, Lin BJ, Chang Y-Y, Shi H-Y. Impact of pay-for-performance on mortality in diabetes patients in Taiwan: A population-based study. Medicine 2016;95. 51.Yen SM, Kung PT, Sheen YJ, Chiu LT, Xu XC, Tsai WC. Factors related to continuing care and interruption of P4P program participation in patients with diabetes. Am J Manag Care 2016;22:e18-30. 52.Kubacki M, Carter C, Herrera ADL, Wang J, Lopez JM, Piech CT. Health plan retention and pharmacy costs of newly diagnosed patients with chronic kidney disease in a managed care population. Am Health Drug Benefits 2009;2:283-90. 53.Rubin DB. Estimating Causal Effects from Large Data Sets Using Propensity Scores. Annals of Internal Medicine 1997;127:757-63. doi: 10.7326/0003-4819-127-8_Part_2-199710151-00064. 54.Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005;43:1130-9. doi: 10.1097/01.mlr.0000182534.19832.83. 55.Glasheen WP, Renda A, Dong Y. Diabetes Complications Severity Index (DCSI)—Update and ICD-10 translation. Journal of Diabetes and its Complications 2017;31:1007-13. doi: https://doi.org/10.1016/j.jdiacomp.2017.02.018. 56.Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986;51:1173-82. doi: 10.1037//0022-3514.51.6.1173. 57.Fagan PJ, Schuster AB, Boyd C, et al. Chronic Care Improvement in Primary Care: Evaluation of an Integrated Pay-for-Performance and Practice-Based Care Coordination Program among Elderly Patients with Diabetes. Health Services Research 2010;45:1763-82. doi: https://doi.org/10.1111/j.1475-6773.2010.01166.x. 58.McAlister FA, Youngson E, Bakal JA, Kaul P, Ezekowitz J, van Walraven C. Impact of physician continuity on death or urgent readmission after discharge among patients with heart failure. Canadian Medical Association Journal 2013;185:E681. doi: 10.1503/cmaj.130048. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/82365 | - |
| dc.description.abstract | "目標： 在慢性疾病中，以糖尿病與慢性腎臟病的醫療花費最高，因此陸續推行「糖尿病」及「初期慢性腎臟病」改善方案。本研究將針對這兩項方案的參與情形，對於糖尿病合併初期慢性腎臟病患之照護利用、費用與結果進行探討，並分析照護連續性是否為中介變項。 方法： 本研究使用兩百萬人抽樣檔，篩選糖尿病合併初期慢性腎臟病患，並分成「僅參加糖尿病P4P」和「兩項P4P皆參加」兩組，經配對後最終共納入1,016位，並以廣義估計方程式及差異中的差異法，評估在控制各變項後，P4P方案對病患照護利用、費用及結果之影響，並探討照護連續性是否為中介變項。 結果： 在P4P介入當年，兩項P4P皆參加的因糖尿病及全因性住院次數皆較低，而在介入後一年的總醫療點數及全因性住院次數皆較低；此外，照護連續性與門診就醫次數、總醫療點數、因糖尿病住院次數和全因性住院次數有關。 結論： 在P4P介入後，參加兩項P4P者可降低總醫療費用、因糖尿病和全因性住院次數，且當照護連續性越高，總醫療費用、門診就醫次數、因糖尿病和全因性住院次數皆較低。" | zh_TW |
| dc.description.provenance | Made available in DSpace on 2022-11-25T07:29:46Z (GMT). No. of bitstreams: 1 U0001-0307202122270500.pdf: 2248550 bytes, checksum: 591834b36bb4d224c3c767c6b09ad9fe (MD5) Previous issue date: 2021 | en |
| dc.description.tableofcontents | 中文摘要 III ABSTRACT IV 目錄 V 表目錄 VII 圖目錄 VIII 第一章 緒論 1 第一節 研究背景與動機 1 第二節 研究目的 3 第三節 研究重要性 4 第二章 文獻探討 5 第一節 糖尿病與慢性腎臟病之介紹 5 第二節 論質計酬制度與方案之介紹 13 第三節 照護連續性之定義、測量及相關研究 32 第四節 論質計酬方案成效之實證研究 39 第五節 綜合評論 53 第三章 研究方法 54 第一節 研究設計與架構 54 第二節 研究假說 57 第三節 研究對象 58 第四節 資料來源與資料處理流程 60 第五節 研究變項操作型定義 64 第四章 研究結果 72 第一節 描述性統計 72 第二節 雙變項分析 76 第三節 多變項分析 93 第五章 討論 112 第一節 研究結果 112 第二節 研究限制 114 第六章 結論與建議 115 第一節 結論 115 第二節 建議 116 參考文獻 118 | |
| dc.language.iso | zh-TW | |
| dc.subject | 論質計酬 | zh_TW |
| dc.subject | 糖尿病 | zh_TW |
| dc.subject | 照護結果 | zh_TW |
| dc.subject | 初期慢性腎臟病 | zh_TW |
| dc.subject | 照護費用 | zh_TW |
| dc.subject | diabetes | en |
| dc.subject | outcome of care | en |
| dc.subject | cost of care | en |
| dc.subject | early kidney disease | en |
| dc.subject | P4P | en |
| dc.title | 論質計酬及照護連續性對糖尿病初期腎病患者醫療照護利用、費用及結果之影響 | zh_TW |
| dc.title | "Impacts of pay for performance and care continuity on utilization, costs and outcomes of medical care among diabetic patients with early kidney disease" | en |
| dc.date.schoolyear | 109-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 楊銘欽(Hsin-Tsai Liu),洪冠予(Chih-Yang Tseng) | |
| dc.subject.keyword | 糖尿病,初期慢性腎臟病,論質計酬,照護費用,照護結果, | zh_TW |
| dc.subject.keyword | diabetes,early kidney disease,P4P,cost of care,outcome of care, | en |
| dc.relation.page | 123 | |
| dc.identifier.doi | 10.6342/NTU202101255 | |
| dc.rights.note | 同意授權(全球公開) | |
| dc.date.accepted | 2021-07-05 | |
| dc.contributor.author-college | 公共衛生學院 | zh_TW |
| dc.contributor.author-dept | 健康政策與管理研究所 | zh_TW |
| dc.date.embargo-lift | 2023-12-31 | - |
| 顯示於系所單位： | 健康政策與管理研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| U0001-0307202122270500.pdf | 2.2 MB | Adobe PDF | 檢視/開啟 |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。